DAYBUE™ (trofinetide): Audience

DAYBUE™ (trofinetide) is the only FDA-approved treatment specifically for Rett syndrome, a neurodevelopmental disorder. Neuren Pharmaceuticals is focused on developing innovative therapies for serious neurological disorders that emerge in early childhood.